Consolidated Statutes and Regulations
Annual Statutes and Regulations
Québec Official Publisher
Policy of the Minister of Justice
Laws: Provisions not in force
Laws: Provisions brought into force
Annual Statutes: PDF versions since 1996
Annual Regulations: PDF versions since 1996
O-7, r. 10
- Regulation respecting the medications that an optometrist may administer
Table of contents
Replaced on 19 July 2018
This document has official status.
O-7, r. 10
Regulation respecting the medications that an optometrist may administer
OPTOMETRIST — LIST OF MEDICATIONS — CONDITIONS FOR ADMINISTRATION
(chapter O-7, s. 19.4, 1st par.)
Replaced, O.C. 845-2018, 2018 G.O. 2, 2760; eff. 2018-07-19; see
chapter O-7, r. 11.1
Every optometrist holding a permit referred to in section 19.2 of the Optometry Act (chapter O-7) may, only for the purpose of examining a patient’s eyes, administer the medications provided for in Schedule I.
O.C. 1453-95, s. 1
An optometrist shall question the patient in advance so as to avoid administering medications that are contra-indicated for the patient and to eliminate any risk of the spread of diseases transmissible by tears or by the conjunctiva.
O.C. 1453-95, s. 2
An optometrist shall follow scientific principles and take into account recent scientific data. More particularly, he shall take all the precautions dictated by the circumstances
when administering medications to children or to the elderly; and
when practising his profession in an area where access to emergency medical services is limited.
O.C. 1453-95, s. 3
An optometrist shall take a patient’s intraocular pressure prior to the dilation of the pupil with a medication having a mydriatic effect and, where indications of an abnormality have been detected, 30 minutes after the dilation.
O.C. 1453-95, s. 4
An optometrist shall evaluate the angle of the anterior chamber of the eye before administering a medication having a mydriatic effect.
O.C. 1453-95, s. 5
An optometrist shall take the necessary measures to minimize the systemic absorption of a medication.
O.C. 1453-95, s. 6
O.C. 1453-95, s. 7
— Benoxinate (maximum concentration 0.4%), alone or combined;
— Proparacaine (maximum concentration 0.5%).
— Tropicamide (maximum concentration 1.0%);
— Phenylephrine (maximum concentration 2.5%).
— Cyclopentolate (maximum concentration 1.0%);
— Homatropine (maximum concentration 2.0%).
— Pilocarpine (maximum concentration 1.0%).
O.C. 1453-95, Sch. I
O.C. 1453-95, 1995 G.O. 2, 3134
Select this element
Select parent element
Copy to Drafting
Copy to LAW
Copy to Clipboard
To copy : Ctrl+C
© Gouvernement du Québec
Selections in current document
All selections in the collection
Delete all selections